Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of 5-day Azacitidine for Patients With Lower-risk Myelodysplastic Syndrome

NCT01652781 is registered in ClinicalTrials.gov with Seoul St. Mary's Hospital as lead sponsor.

NCT NCT01652781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01652781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of 5-day Azacitidine for Patients With Lower-risk Myelodysplastic Syndrome
Lead sponsor
Seoul St. Mary's Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2012
Completion date
December 31, 2016
Enrollment
92 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndrome